Idiopathic Pulmonary Fibrosis Job Exposures Study
IPFJES
1 other identifier
observational
960
1 country
1
Brief Summary
A case-control study to investigate whether job exposures are an under-recognized cause of idiopathic pulmonary fibrosis (IPF) using an interview to collect information about previous jobs and a blood test to investigate genetic susceptibility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 2, 2017
CompletedFirst Posted
Study publicly available on registry
July 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2019
CompletedDecember 12, 2019
December 1, 2019
2.4 years
May 2, 2017
December 10, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between asbestos exposure and IPF
estimated using logistic regression for any vs no asbestos exposure and adjusting for age and smoking status
2 years
Secondary Outcomes (2)
Dose-response relationship between asbestos exposure and IPF
2 years
Gene-environment interaction (for MUC5B rs35705950 and asbestos exposure) odds ratio.
2 years
Study Arms (2)
Case
Males with an incident diagnosis of IPF made between the 1st of February 2017 and the 5th of October 2019.
Controls
Males with an incident hospital outpatient attendance between the 1st of February 2017 and the 5th of October 2019 who do not have a diagnosis of IPF. At each participating centre a control clinic is randomly selected from all control clinics that the research team is able to recruit from; this clinic is the source clinic for controls for the duration of the study.
Interventions
Eligibility Criteria
Hospital based
You may qualify if:
- New diagnosis of IPF between February 2017 and October 2019
You may not qualify if:
- Unable to give informed consent
- Ever worked outside of the UK
- For controls
- New outpatient department attendee between February 2017 and October 2019
- Unable to give informed consent
- Ever worked outside of the UK (does not include work outside the UK by members of the armed forces or merchant navy)
- Diagnosis of IPF
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Imperial College Londonlead
- Wellcome Trustcollaborator
- University Hospital Southampton NHS Foundation Trustcollaborator
- Imperial College Healthcare NHS Trustcollaborator
- Heart of England NHS Foundation Trustcollaborator
- Liverpool University Hospitals NHS Foundation Trustcollaborator
- Papworth Hospital NHS Foundation Trustcollaborator
- Nottingham University Hospitals NHS Trustcollaborator
- University Hospital of South Manchestercollaborator
- Guy's and St Thomas' NHS Foundation Trustcollaborator
- North Bristol NHS Trustcollaborator
- The Leeds Teaching Hospitals NHS Trustcollaborator
- Newcastle-upon-Tyne Hospitals NHS Trustcollaborator
- Royal Devon and Exeter NHS Foundation Trustcollaborator
- Somerset NHS Foundation Trustcollaborator
- Royal Infirmary of Edinburghcollaborator
- Morriston Hospitalcollaborator
- Aberdeen Royal Infirmarycollaborator
- Worcestershire Acute Hospitals NHS Trustcollaborator
- University Hospital Birmingham NHS Foundation Trustcollaborator
- Portsmouth Hospitals NHS Trustcollaborator
- Norfolk and Norwich University Hospitals NHS Foundation Trustcollaborator
- Glasgow Royal Infirmarycollaborator
Study Sites (1)
Imperial Healthcare NHS Trust
London, United Kingdom
Related Publications (1)
Reynolds CJ, Sisodia R, Barber C, Moffatt M, Minelli C, De Matteis S, Cherrie JW, Newman Taylor A, Cullinan P. What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case-control study. Occup Environ Med. 2023 Feb;80(2):97-103. doi: 10.1136/oemed-2022-108404. Epub 2023 Jan 12.
PMID: 36635100DERIVED
Related Links
Biospecimen
blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Carl Reynolds
Imperial College London
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2017
First Posted
July 7, 2017
Study Start
May 1, 2017
Primary Completion
October 5, 2019
Study Completion
October 5, 2019
Last Updated
December 12, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share